Microorganism from the ocean shows a potential novel pharmacological treatment to improve stroke recovery
Newswise — A new study using brevetoxin-2, a compound produced naturally by marine algae, stimulated nerve cell growth and plasticity in cultured mouse neurons. This research advances a potentially new pharmacological treatment to aid recovery of brain function following a stroke or other traumatic brain injury.
Stroke is a leading cause of death in the United States with more than 795,000 people suffering a stroke each year, according to the Center for Disease Control. Stroke is a leading cause of serious long-term disability and there is currently no drug treatment for post-stroke rehabilitation.
“Our research suggests that compounds like brevetoxin-2 can augment neuronal plasticity potentially providing a neural repair therapy for stroke recovery. If that outcome can be supported by further studies in animals and subsequently humans, it could have a profound impact on a currently non-treatable condition,” said Thomas F. Murray, Ph.D. associate vice president for Health Science Research and professor and chair of the Department of Pharmacology, Creighton School of Medicine.
The research team from Creighton University School of Medicine, University of North Carolina Wilmington, and Scripps Institution of Oceanography published their findings in the Nov. 12 online edition of the journal Proceedings of the National Academy of Sciences (PNAS).
The tiny marine dinoflagellate Karenia brevis produces brevetoxin, which in high concentrations is responsible for the harmful algal blooms known as red tides that occur in the waters off the west coast of Florida. The neurotoxin-laden red tide causes respiratory irritation in humans and central nervous system paralysis in fish.
“Brevetoxin is a neurotoxin that is known to activate nerves cells to fire spontaneously,” said Dan Baden, Ph.D. He is director of the Center for Marine Science as well as a founding member and Executive Principal of MARBIONC at University of North Carolina Wilmington. “It’s a great advancement to show that this naturally occurring ocean compound can stimulate nerve cell growth in cultured mouse cells.”
Brevetoxin is one of more than 1,000 ocean organisms cultured at the University of North Carolina Wilmington’s MARBIONC facility (Marine Biotechnology in North Carolina) for use in bio-medical research. The bioactive materials from Karenia brevis have been actively studied by Baden since the early 1970s.
A clot that restricts blood flow to an area of the brain causes a stroke. Although the dead tissue cannot be revived, the brain can be trained to redirect nerve impulses to living nerve cells nearby.
Recent scientific studies have shown that rewiring of nerve cells following a stroke occurs as a result of heightened plasticity around the brain’s damaged cerebral cortex, which is the area of the brain responsible for sensory and cognitive nervous system functions.
This new study showed enhanced neuronal sprouting, the growth of axons or dendrites of a nerve cell as well the formation of new synapses between nerve cells in mouse neurons in a culture dish.
The paper is titled ““Bidirectional influence of sodium channel activation on NMDA receptor-dependent cerebrocortical neuron structural plasticity.” A copy of the study can be found here.
About Creighton University
Creighton University, a comprehensive Jesuit, Catholic institution, was founded in 1878 in Omaha, Neb. The University enrolls more than 4,200 undergraduate and 3,500 professional school and graduate students in the College of Arts and Sciences, College of Business, Graduate School, and Schools of Dentistry, Law, Medicine, Nursing, and Pharmacy and Health Professions.
The Creighton University School of Medicine has been teaching tomorrow’s doctors since 1892. The school is committed to providing excellent patient care and preparing future doctors for the medical challenges and opportunities that lie ahead in patient care, teaching and research. In 2009, the School created an academic affiliation with St. Joseph’s Hospital and Medical Center in Phoenix, Ariz., creating a Creighton medical school presence in Phoenix. In 2012, Creighton University and Alegent Health created an expanded affiliation as the primary teaching partner for Creighton’s School of Medicine. The new Alegent Creighton Health will further the missions of both faith-based organizations by improving healthcare and transforming medical education for the benefit of physicians, students and the community.
The University of North Carolina Wilmington, founded in 1947, is one of 17 institutions in the UNC system. The university enrolls more than 13,000 undergraduate and graduate students in the College Arts and Sciences, the College of Health and Human Services, the Watson College of Education, the Cameron School of Business and the Graduate School. UNCW is committed to three enduring values: the journey of learning, the love of place and the power of ideas and innovation.
The UNCW Center for Marine Science has fostered a multidisciplinary approach to marine research for more than 30 years. The center promotes basic and applied research in the fields of oceanography, coastal and wetland studies, marine biomedical and environmental physiology, aquaculture and marine biotechnology.